Earnings Ahead

FMS - Fresenius Medical Care Corporation

33.41 -0.02 -0.06

Fresenius Medical Care Corporation

Fresenius Medical Care Corporation

About

Profile


Headquarters

Bad Homburg vor der Höhe, Germany


Intraday

High
-
Low
-

52-week

High
-
Low
-

FMS



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Warning: FMS is at high risk of cutting its dividend
  • Fresenius stock rises as Q4 revenue grows, plans restructuring; sees 'headwinds' in FY23
  • Fresenius Medical Care Q4 2022 Earnings Preview
  • Fresenius considering deconsolidating dialysis subsidiary - Bloomberg
  • Dr. Reddy's prepare to file for Rituxan biosimilar in US, EU as trials completed
  • Fresenius Medical Care CFO takes over as CEO amid focus on 'operational turnaround'
  • Off-patent drugs make up 91% of prescriptions, but only 18% of spending - report
  • Fresenius under pressure to make changes as activist Elliott takes 3% stake - Bloomberg
  • Fresenius Q3 net income falls amid labor market woes, cuts FY22 outlook on slower recovery
  • Fresenius Medical gains after report of activist Elliott stake in Fresenius SE
  • Fresenius cut to Hold at Jefferies citing staffing issues and inflation
  • Cara's partner files for Japanese approval of Korsuva to treat itch in hemodialysis patients
  • Fresenius gets award to provide dialysis services to U.S. military veterans
  • Fresenius appoints head of pharma unit as new CEO
  • Cara, Vifor's Kapruvia gets approval in Switzerland to treat itch in hemodialysis patients
  • Vifor Fresenius' rare autoimmune disease drug Tavneos gets UK NICE backing
  • DaVita stock dips as peer Fresenius outlook weighed down by labor cost, inflation
  • Fresenius stock slumps 13% as labor costs, inflation impact leads to FY22 outlook cut; 2025 targets withdrawn
  • Fresenius slips as U.S. joins whistleblower lawsuit over Medicare fraud
  • DaVita falls 10% after Supreme Court ruling in dialysis coverage case
PEERS
/XLV

XLV

Earnings History

Date EPS / Forecast Revenue / Forecast
February 22, 2022 0.5101 / 0.4964 5.27B / 5.2B Beat!
November 2, 2021 0.5443 / 0.5523 5.14B / 5.3B
July 30, 2021 0.4506 / 0.4728 5.12B / 5.21B
May 6, 2021 0.5125 / 0.4748 5.09B / 5.1B
February 23, 2021 0.7677 / 0.7588 5.35B / 5.6B
October 29, 2020 0.7053 / 0.674 5.15B / 5.34B
July 30, 2020 0.7077 / 0.62 5.37B / 5.23B Beat!
May 27, 2020 0.5212 / 0.48 4.92B / 4.84B Beat!
February 19, 2020 0.7339 / 0.65 4.91B / 5B
October 29, 2019 0.67 / 0.66 4.91B / 4.91B
July 30, 2019 0.92 / 0.56 4.35B / 4.85B
July 29, 2019 0.47 / 0.55 4.84B / 4.85B
May 1, 2019 0.58 / 0.53 4.61B / 4.58B Beat!
February 19, 2019 0.75 / 0.7 4.88B / 4.9B
October 30, 2018 0.57 / 0.63 4.61B / 4.8B
August 2, 2018 0.52 / 0.62 4.93B / 5.01B
May 3, 2018 0.54 / 0.59 4.75B / 5.22B
February 27, 2018 - / 0.7 - / 5.28B
November 2, 2017 0.59 / 0.56 4.34B / 5.14B
August 1, 2017 0.48 / 0.5 4.47B / 4.75B
May 3, 2017 - / 0.44 4.55B / - Beat!
February 22, 2017 0.64 / 0.62 4.69B / 4.74B
October 27, 2016 0.54 / 0.52 4.60B / 4.60B